Osaic Holdings’s Lucid Diagnostics LUCD Stock Holding History
Bought
Maintained
Sold
Other funds holding LUCD
TSC
MCM
Osaic Holdings's LUCD Position: Q2 2026 in Review
Osaic Holdings reduced its Lucid Diagnostics (LUCD) stake by 2.1% in Q2 2026, selling an estimated $515 and leaving 22,292 shares worth $23.9K. The position accounts for ﹤0.01% of the portfolio, ranked #6040.
Osaic Holdings first reported a position in LUCD in Q2 2022 and has held it in 17 quarters since. The position peaked at $26.2K in Q1 2026. 116 funds tracked by Wall St. Rank hold LUCD as of Q2 2026.
- Osaic Holdings held 22,292 shares of Lucid Diagnostics worth $23.9K as of Q2 2026.
- Osaic Holdings sold 478 Lucid Diagnostics shares in Q2 2026, an estimated $515.
- Lucid Diagnostics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6040 holding.
- Osaic Holdings first reported a position in Lucid Diagnostics in Q2 2022 and has held it in 17 quarters since.
- Osaic Holdings's Lucid Diagnostics position peaked at $26.2K in Q1 2026.
- 116 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q2 2026.
Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.